ScienceDex / Researcher record
Ermilov, Sergey A
- Tomowave Laboratories, Inc. (no department on record)
From the FY2014 NIH awards this investigator leads as contact PI. The department is the award's.
NIH Funding · FY2014
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2014 | $200,805 | 1 | #31,187 |
| 2017 | $211,480 | 1 | #31,081 |
| 2018 | $279,143 | 1 | #29,741 |
| 2019 | $55,000 | 1 | #42,159 |
| 2022 | $997,451 | 1 | #9,897 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY2014 · selected1 record
- FY20171 record
- FY20181 record
- FY20191 record
- FY20221 record
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2014 through FY2022Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2014 award records by amount
NIH award records listing Ermilov, Sergey A as a PI. Multi-PI records show the full award amount for context.
- 1R43CA177148-01A1R43Contact PIOptoacoustic tomography system for image-guided cryotherapy of prostate cancer$200.8Kaward amount
Award organization
Organizations that administered FY2014 awards listing Ermilov, Sergey A as a PI.
FY2014 award administered by Tomowave Laboratories, Inc. ().
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2014First NIH AwardTomowave Laboratories, Inc.
- 2018$500K Cumulative Funding
- 2022$1M Cumulative Funding
- 2022Entered Top 50% NationallyRanked #9897